← Open Payments lookup

ALVINE METOHO-EKE: Open Payments

NPI 1306461934 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,003 in 43 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $250 · 2025 $1,003

Food & beverage: $1,003
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$294
Neurocrine BioSciences, Inc.5$151
Vanda Pharmaceuticals Inc.5$132
ABBVIE INC.6$109
Otsuka America Pharmaceutical, Inc.6$105
Lundbeck LLC2$59
Teva Pharmaceuticals USA, Inc.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Janssen Pharmaceuticals, Inc1$25
Alkermes, Inc.1$23

Products named: COBENFY, INGREZZA, FANAPT, OPDIVO, VRAYLAR, ABILIFY MAINTENA, ABILIFY ASIMTUFII, UZEDY.

Industry payments across TX — which companies pay providers there.